Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial.

Kristal AR, Arnold KB, Neuhouser ML, Goodman P, Platz EA, Albanes D, Thompson IM.

Am J Epidemiol. 2010 Sep 1;172(5):566-77. doi: 10.1093/aje/kwq148. Epub 2010 Aug 6.

2.

A high ratio of dietary n-6/n-3 polyunsaturated fatty acids is associated with increased risk of prostate cancer.

Williams CD, Whitley BM, Hoyo C, Grant DJ, Iraggi JD, Newman KA, Gerber L, Taylor LA, McKeever MG, Freedland SJ.

Nutr Res. 2011 Jan;31(1):1-8. doi: 10.1016/j.nutres.2011.01.002.

PMID:
21310299
3.

Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.

Gong Z, Neuhouser ML, Goodman PJ, Albanes D, Chi C, Hsing AW, Lippman SM, Platz EA, Pollak MN, Thompson IM, Kristal AR.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1977-83.

4.

Vitamin E and selenium supplementation and risk of prostate cancer in the Vitamins and lifestyle (VITAL) study cohort.

Peters U, Littman AJ, Kristal AR, Patterson RE, Potter JD, White E.

Cancer Causes Control. 2008 Feb;19(1):75-87. Epub 2007 Oct 18.

PMID:
17943452
5.

Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men.

Rodriguez C, McCullough ML, Mondul AM, Jacobs EJ, Fakhrabadi-Shokoohi D, Giovannucci EL, Thun MJ, Calle EE.

Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):597-603.

6.

Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Leitzmann MF, Ahn J, Albanes D, Hsing AW, Schatzkin A, Chang SC, Huang WY, Weiss JM, Danforth KN, Grubb RL 3rd, Andriole GL; Prostate, Lung, Colorectal, and Ovarian Trial Project Team.

Cancer Causes Control. 2008 Dec;19(10):1267-76. doi: 10.1007/s10552-008-9198-6. Epub 2008 Jul 10.

PMID:
18618278
7.

Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Thompson IM, Ankerst DP, Chi C, Goodman PJ, Tangen CM, Lucia MS, Feng Z, Parnes HL, Coltman CA Jr.

J Natl Cancer Inst. 2006 Apr 19;98(8):529-34.

8.

A prospective study of dietary alpha-linolenic acid and the risk of prostate cancer (United States).

Koralek DO, Peters U, Andriole G, Reding D, Kirsh V, Subar A, Schatzkin A, Hayes R, Leitzmann MF.

Cancer Causes Control. 2006 Aug;17(6):783-91.

PMID:
16783606
9.

Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Ahn J, Albanes D, Peters U, Schatzkin A, Lim U, Freedman M, Chatterjee N, Andriole GL, Leitzmann MF, Hayes RB; Prostate, Lung, Colorectal, and Ovarian Trial Project Team.

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2623-30.

10.

Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York.

McCann SE, Ambrosone CB, Moysich KB, Brasure J, Marshall JR, Freudenheim JL, Wilkinson GS, Graham S.

Nutr Cancer. 2005;53(1):33-41.

PMID:
16351504
11.

Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial.

Kristal AR, Till C, Platz EA, Song X, King IB, Neuhouser ML, Ambrosone CB, Thompson IM.

Cancer Epidemiol Biomarkers Prev. 2011 Apr;20(4):638-46. doi: 10.1158/1055-9965.EPI-10-1221. Epub 2011 Feb 18.

12.

Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Brasky TM, Darke AK, Song X, Tangen CM, Goodman PJ, Thompson IM, Meyskens FL Jr, Goodman GE, Minasian LM, Parnes HL, Klein EA, Kristal AR.

J Natl Cancer Inst. 2013 Aug 7;105(15):1132-41. doi: 10.1093/jnci/djt174. Epub 2013 Jul 10.

13.

Boron intake and prostate cancer risk.

Gonzalez A, Peters U, Lampe JW, White E.

Cancer Causes Control. 2007 Dec;18(10):1131-40. Epub 2007 Sep 12.

PMID:
17851770
14.

Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials.

Neuhouser ML, Kristal AR, Patterson RE, Goodman PJ, Thompson IM.

Nutr Cancer. 2001;39(1):12-8.

PMID:
11588893
15.

PCPT: Evidence that finasteride reduces risk of most frequently detected intermediate- and high-grade (Gleason score 6 and 7) cancer.

Kaplan SA, Roehrborn CG, Meehan AG, Liu KS, Carides AD, Binkowitz BS, Heyden NL, Vaughan ED Jr.

Urology. 2009 May;73(5):935-9. doi: 10.1016/j.urology.2008.09.079. Epub 2009 Mar 28.

PMID:
19328538
16.

Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy.

Antonelli JA, Jones LW, Bañez LL, Thomas JA, Anderson K, Taylor LA, Gerber L, Anderson T, Hoyo C, Grant D, Freedland SJ.

J Urol. 2009 Nov;182(5):2226-31. doi: 10.1016/j.juro.2009.07.028. Epub 2009 Sep 16.

PMID:
19758620
17.

Fatty acids and risk of prostate cancer in a nested case-control study in male smokers.

Männistö S, Pietinen P, Virtanen MJ, Salminen I, Albanes D, Giovannucci E, Virtamo J.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1422-8.

18.

Vitamin E supplements and risk of prostate cancer in U.S. men.

Rodriguez C, Jacobs EJ, Mondul AM, Calle EE, McCullough ML, Thun MJ.

Cancer Epidemiol Biomarkers Prev. 2004 Mar;13(3):378-82.

19.

Prevalence of prostate cancer among men with a prostate-specific antigen level < or =4.0 ng per milliliter.

Thompson IM, Pauler DK, Goodman PJ, Tangen CM, Lucia MS, Parnes HL, Minasian LM, Ford LG, Lippman SM, Crawford ED, Crowley JJ, Coltman CA Jr.

N Engl J Med. 2004 May 27;350(22):2239-46. Erratum in: N Engl J Med. 2004 Sep 30;351(14):1470.

20.

Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors.

West DW, Slattery ML, Robison LM, French TK, Mahoney AW.

Cancer Causes Control. 1991 Mar;2(2):85-94.

PMID:
1873441
Items per page

Supplemental Content

Write to the Help Desk